Violet Wai-Fan Yuen

Chinese University of Hong Kong

Papers

2

Total Citations

7

H-Index

2

About

Violet Wai-Fan Yuen is a pioneering urologic surgeon and researcher whose work is reshaping the landscape of minimally invasive oncologic surgery. Her primary research areas center on robotic-assisted surgical techniques and the prevention of postoperative complications in urologic oncology. Dr. Yuen’s most impactful contribution is her leadership of the first randomized controlled trial (2022) evaluating Hemopatch for preventing lymphatic leaks after robotic prostatectomy and pelvic lymph node dissection—a study that has garnered 4 citations and directly addresses a common, morbid complication of this procedure. More recently, she has broken new ground with the VIABLE trial (2025), introducing the first-ever transurethral robotic platform for en bloc resection of bladder tumors. This phase I study, with 3 citations, represents a paradigm shift in bladder cancer management, moving from traditional fragmented resection to precise, whole-tumor removal. By pioneering these novel technologies and rigorously testing them through clinical trials, Dr. Yuen is not only improving patient outcomes but also defining the future of robotic urologic surgery. Her work stands at the intersection of surgical innovation and evidence-based practice, making her a rising leader in the field.

Research Focus

Key Achievements

2
H-Index
2
Papers
7
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Hemopatch to Prevent Lymphatic Leak after Robotic Prostatectomy and Pelvic Lymph Node Dissection: A Randomized Controlled Trial
4 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Chinese University of Hong Kong

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago